Moshe Spinowitz advises multinational companies in connection with cross-border mergers and acquisitions, and post-acquisition restructuring and integration transactions. He also advises clients on a range of tax controversy matters during all phases of IRS audits and appeals.
Mr. Spinowitz’s experience includes advising multinational companies in connection with the integration and restructuring of their operations following large cross-border acquisitions, advising pharmaceutical and technology companies in connection with the structuring of their intellectual property holdings, and successfully representing several multinational corporations before IRS appeals in connection with intercompany financing transactions. Select representations include:
- Juno Therapeutics in its pending $9 billion acquisition by Celgene;
- Gilead in its acquisition of Cell Design Labs for up to $567 million;
- WeWork in its $4.4 billion investment from SoftBank Group and SoftBank Vision Fund;
- Biogen, Inc. in the spin-off of its hemophilia business into the independent public company Bioverativ;
- Konecranes plc in its acquisition of Terex Corporation’s material handling and port solutions unit for $1.28 billion;
- Merrimack Pharmaceuticals, Inc. in its sale of cancer treatment drugs Onivyde and generic Doxil to Ipsen S.A. for up to $1.025 billion;
Prior to joining Skadden, Mr. Spinowitz served as a law clerk to Judge Michael Boudin on the United States Court of Appeals for the First Circuit, and Justice Antonin Scalia on the United States Supreme Court.
- J.D., Harvard Law School, 2006 (magna cum laude; Articles Editor, Harvard Law Review)
- B.A., Harvard College, 2002 (summa cum laude)
- District of Columbia
- Law Clerk to Judge Michael Boudin, U.S. Court of Appeals for the First Circuit
- Law Clerk to Associate Justice Antonin Scalia, U.S. Supreme Court
Rate : $$$$